Amit Kumar's most recent trade in Anixa Biosciences Inc was a trade of 5,000 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on July 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.16 per share. | 30 Jul 2025 | 5,000 | 579,925 (2%) | 0% | 3.2 | 15,800 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 11 Jul 2025 | 5,000 | 574,925 (2%) | 0% | 3.2 | 15,750 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 04 Jun 2025 | 10,000 | 569,925 (2%) | 0% | 2.9 | 28,500 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 15 Jan 2025 | 43,000 | 559,925 (2%) | 0% | 2.2 | 95,890 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 700,000 | 700,000 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.41 per share. | 07 Jun 2024 | 25,000 | 516,925 (2%) | 0% | 2.4 | 60,250 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.22 per share. | 15 Mar 2024 | 30,000 | 491,925 (2%) | 0% | 3.2 | 96,600 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 700,000 | 700,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 28 Jul 2023 | 40,000 | 502,100 (2%) | 0% | 2.6 | 103,000 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2023 | 40,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 28 Jul 2023 | 28,375 | 473,725 (2%) | 0% | 3.6 | 103,001 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 28 Jul 2023 | 11,800 | 461,925 (2%) | 0% | 3.6 | 42,126 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 700,000 | 700,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2022 | 640,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 15 Sep 2022 | 640,000 | 954,000 (4%) | 3% | 2.6 | 1,648,000 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.48 per share. | 15 Sep 2022 | 491,900 | 462,100 (2%) | 2% | 4.5 | 2,203,712 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 07 Jan 2022 | 20,000 | 314,000 (1%) | 0% | 3 | 60,000 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.77 per share. | 29 Oct 2021 | 2,000 | 294,000 (1%) | 0% | 4.8 | 9,540 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.28 per share. | 23 Jul 2021 | 5,000 | 292,000 (1%) | 0% | 4.3 | 21,400 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.94 per share. | 16 Jul 2021 | 10,000 | 287,000 (1%) | 0% | 3.9 | 39,400 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2021 | 2,000,000 | 2,000,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 May 2021 | 1,500,000 | 0 | - | - | Restricted Stock Award | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2021 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 25 Mar 2021 | 5,000 | 277,000 (1%) | 0% | 4.9 | 24,300 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.73 per share. | 29 Jan 2021 | 10,000 | 272,000 (1%) | 0% | 3.7 | 37,300 | Common Stock |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2020 | 1,000,000 | 1,000,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 11 Sep 2020 | 28,000 | 262,000 (1%) | 0% | 2.1 | 59,080 | Common Stock |